Skip to main content
. Author manuscript; available in PMC: 2017 Jan 18.
Published in final edited form as: Nature. 2016 Mar 30;532(7598):195–200. doi: 10.1038/nature17623

Figure 3. CSPG production by non-astrocyte cells in SCI lesions after ablation or attenuation of astrocyte scars.

Figure 3

(a) Dot blots and quantitation of total CSPG detected by CS56 antibody relative to total protein (Ponceau). n = 4; * p<0.05 versus uninjured (ANOVA with Newman-Keuls). (b) CS56 and GFAP immunohistochemistry (see Extended Data Fig. 2). (c) Details of boxed areas in b showing CSPG production by GFAP-negative cells.